212 products were found matching "K04362"!

1 from 18 pages
No results were found for the filter!
FGFR1, active human recombinant protein
FGFR1, active human recombinant protein

Item number: BPS-40210

Active recombinant human FGFR1 (399-822) was expressed by baculovirus in Sf9 insect cells using a N-terminal GST tag. The gene accession number is NM_023110. Application: Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling.
Keywords: N-sam, CD331, BFGFR, FLT-2, FGFR1, FGFR-1, bFGF-R-1, Proto-oncogene c-Fgr, Fms-like tyrosine kinase 2, Fibroblast growth...
Application: Enzyme kinetics, inhibitor screening
MW: 73 kD
862.00€ *
Review
NEW
ASP5878
ASP5878

Item number: Cay41841-1

ASP5878 is an inhibitor of wild-type FGFR1, -2, -3, and -4 (IC50s = 0.47, 0.6, 0.74, and 3.5 nM, respectively) and mutant FGFR3K650E, FGFR3K560M, and FGFR4N535K (IC50s = 1.6, 4.2, and 78 nM, respectively). It is selective for these FGFRs over a panel of 128 additional kinases at 200 nM but does inhibit VEGFR2 and...
Keywords: 4-[[5-[(2,6-difluoro-3,5-dimethoxyphenyl)methoxy]-2-pyrimidinyl]amino]-1H-pyrazole-1-ethanol
Application: Wild-type/mutant FGFR inhibitor
CAS 1453208-66-6
MW: 407.4 D
From 54.00€ *
Review
Nintedanib
Nintedanib

Item number: TGM-T1777-50mg

Description: Nintedanib (Intedanib) is a triple vascular kinase inhibitor that inhibits VEGFR1, VEGFR2, and VEGFR3 (IC50=34/13/13 nM), FGFR1, FGFR2, and FGFR3 (IC50=69/37/108 nM), PDGFRalpha, and PDGFRbeta (IC50=59/65 nM). Nintedanib has antitumor activity and inhibits tumor growth by inhibiting angiogenesis....
Keywords: BIBF 1120, Intedanib
Application: Targets FMS-like tyrosine kinase 1 [EC:2.7.10.1] (FLT1, VEGFR1)
CAS 656247-17-5
MW: 539.62 D
From 38.00€ *
Review
AZD4547
AZD4547

Item number: TGM-T1948-100mg

Description: AZD4547, a new-type specific FGFR inhibitor, targets for FGFR1/2/3 (IC50: 0.2/2.5/1.8 nM in cell-free assays). Target: VEGFR, FGFR. Smiles: COc1cc(CCc2cc(NC(=O)c3ccc(cc3)N3C[C@H](C)N[C@H](C)C3)n[nH]2)cc(OC)c1. References: Gavine PR, et al. AZD4547: an orally bioavailable, potent, and selective...
Application: FGFR inhibitor
CAS 1035270-39-3
MW: 463.57 D
From 33.00€ *
Review
Infigratinib
Infigratinib

Item number: TGM-T1975-100mg

Description: Infigratinib (NVP-BGJ398) (BGJ398) is an orally bioavailable pan FGFR inhibitor (IC50: 0.9/1.4/1 nM for FGFR1/2/3), >40-fold selective for FGFR versus FGFR4 and VEGFR2. Target: Apoptosis, FGFR. Smiles: CCN1CCN(CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)cc1. References: Guagnano V, et al....
Keywords: BGJ-398, NVP-BGJ398
Application: Targets fibroblast growth factor receptor 1 [EC:2.7.10.1] (FGFR1, CD331)
CAS 872511-34-7
MW: 560.48 D
From 39.00€ *
Review
Lucitanib
Lucitanib

Item number: TGM-T15185-100mg

Description: Lucitanib (E-3810) is a novel and potent inhibitor of VEGFR and FGFR, selectively targeting VEGFR1, VEGFR2, VEGFR3, FGFR1, and FGFR2 with IC50 values of 7 nM, 25 nM, 10 nM, 17.5 nM, and 82.5 nM, respectively. Target: VEGFR, FGFR. Smiles: CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12....
Keywords: E-3810
Application: Targets fibroblast growth factor receptor 1 [EC:2.7.10.1] (FGFR1, CD331)
CAS 1058137-23-7
MW: 443.49 D
From 40.00€ *
Review
PD-166866
PD-166866

Item number: TGM-T3492-100mg

Description: PD-166866 is a selective FGFR tyrosine kinase inhibitor. Target: Autophagy, FGFR. Smiles: COc1cc(OC)cc(c1)-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C. References: Risuleo G, et al. J Exp Clin Cancer Res. 2009, 28:151.
Keywords: PD166866
Application: FGFR1 inhibitor
CAS 192705-79-6
MW: 396.44 D
From 34.00€ *
Review
E7090
E7090

Item number: TGM-T27234-25mg

Description: E-7090 is a fibroblast growth factor receptor inhibitor. E-7090 is a selective inhibitor of the tyrosine kinase activities of FGFR1, -2, and -3. Target: Others. Smiles: CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(cc4)C4CCN(CCO)CC4)c3)c(OCCOC)cc12. References: Watanabe Miyano S, Yamamoto Y, Kodama K, Miyajima Y,...
Keywords: E-7090, E 7090
Application: Targets fibroblast growth factor receptor 1 [EC:2.7.10.1] (FGFR1, CD331)
CAS 1622204-21-0
MW: 587.67 D
From 2,227.00€ *
Review
Tinengotinib
Tinengotinib

Item number: TGM-T39718-5mg

Description: Tinengotinib, a novel compound, acts as a potent modulator of protein kinases including Aurora kinase and VEGFR kinase. With its unique properties, Tinengotinib holds promise for investigating diseases marked by abnormalities in these kinases, particularly cancer-related conditions (WO2018108079A1)....
Application: Targets aurora kinase A [EC:2.7.11.1] (AURKA)
CAS 2230490-29-4
MW: 394.86 D
290.00€ *
Review
FGFR1 inhibitor-2
FGFR1 inhibitor-2

Item number: TGM-T39992-5mg

Description: FGFR1 inhibitor-2 (with an IC50 of 4.55 µM in MDA-MB-231 cells) is a potent inhibitor of FGFR1. It is specifically useful for studying metastatic triple-negative breast cancer. Target: Others. Smiles: Fc1ccc(cc1)C(CCCCNC(=O)Nc1ccc(c(c1)C(F)(F)F)N(=O)=O)c1ccc(F)cc1. References: Ashraf-Uz-Zaman M, et al....
Keywords: FGFR1 inhibitor-2
Application: FGFR1 inhibitor
CAS 2410612-08-5
MW: 507.461 D
951.00€ *
Review
Zoligratinib
Zoligratinib

Item number: TGM-T6024-100mg

Description: Zoligratinib (CH5183284) is a selective and orally available FGFR inhibitor, which is for FGFR1(IC50=9.3 nM), FGFR2(IC50=7.6 nM), FGFR3(IC50=290), and FGFR4(IC50=22 nM), respectively. Target: FGFR. Smiles: Cc1nc2ccc(cc2[nH]1)-n1ncc(C(=O)c2cc3ccccc3[nH]2)c1N. References: Nakanishi Y, et al. Mol Cancer...
Keywords: FF284, CH5183284, Debio 1347
Application: FGFR1/2/3 inhibitor
CAS 1265229-25-1
MW: 356.38 D
From 39.00€ *
Review
FGF/PDGF/VEGF RTK Inhibitor
FGF/PDGF/VEGF RTK Inhibitor

Item number: TGM-T71944-100mg

Description: FGF/PDGF/VEGF RTK Inhibitor is a potent, reversible, atp-competitive inhibitor against pdgfrbeta, fgfr-1, and vegfr-2 (ic50 = 20, 90, and 240 nm, respectively) and effectively suppresses vegf-stimulated proliferation of hmvecs (ec50 = 420 nm). Target: Others. Smiles:...
Application: FGF/PDGF/VEGF RTK inhibitor
CAS 144335-37-5
MW: 277.28 D
From 1,491.00€ *
Review
1 from 18 pages